Literature DB >> 18371464

Antiplatelet drug nonresponsiveness.

Patrick Gladding1, Mark Webster, John Ormiston, Sarah Olsen, Harvey White.   

Abstract

The response to most medication, including antiplatelet drugs, is highly variable between individuals. Observational studies have shown that nonresponders to antiplatelet agents appear to have an increased incidence of vascular events. This review article reviews the background, mechanisms, and evidence in support of the clinical significance of this phenomenon.

Mesh:

Substances:

Year:  2008        PMID: 18371464     DOI: 10.1016/j.ahj.2007.12.034

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

Review 1.  Antithrombotic therapy for the CardioWest temporary total artificial heart.

Authors:  Christopher R Ensor; William D Cahoon; Michael A Crouch; Gundars J Katlaps; Michael L Hess; Richard H Cooke; Kyle J Gunnerson; Vigneshwar Kasirajan
Journal:  Tex Heart Inst J       Date:  2010

2.  Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel.

Authors:  Bo Jin; Huan-Chun Ni; Wei Shen; Jian Li; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2010-09-16       Impact factor: 2.316

Review 3.  Antiplatelet resistance in stroke.

Authors:  Mehmet Akif Topçuoglu; Ethem Murat Arsava; Hakan Ay
Journal:  Expert Rev Neurother       Date:  2011-02       Impact factor: 4.618

4.  Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.

Authors:  Kenichi Fukushima; Yoshio Kobayashi; Hideki Kitahara; Yo Iwata; Nakabumi Kuroda; Masayuki Ooyama; Fumio Nomura; Issei Komuro
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

5.  Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.

Authors:  Annalisa Dimasi; Marco Rasponi; Filippo Consolo; Gianfranco B Fiore; Danny Bluestein; Marvin J Slepian; Alberto Redaelli
Journal:  Med Eng Phys       Date:  2017-08-30       Impact factor: 2.242

Review 6.  Acute coronary syndromes: advances in antithrombotics.

Authors:  Nilusha Gukathasan; Roxana Mehran
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 7.  [Perioperative management of patients with coronary stents in non-cardiac surgery].

Authors:  C Jámbor; M Spannagl; B Zwissler
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

8.  Anti-platelet Therapy Resistance - Concept, Mechanisms and Platelet Function Tests in Intensive Care Facilities.

Authors:  Alina Mărginean; Claudia Bănescu; Alina Scridon; Minodora Dobreanu
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

9.  P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Authors:  Adriana Dana Oprea; Wanda M Popescu
Journal:  Cardiol Res Pract       Date:  2013-02-19       Impact factor: 1.866

10.  Targeted thrombolysis strategies for neuroprotective effect.

Authors:  Junping Zhang; Guoxing Ma; Zhimin Lv; Yu Zhou; Chunguang Wen; Yaqing Wu; Ruian Xu
Journal:  Neural Regen Res       Date:  2014-07-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.